Potassium channel subfamily K member 12 (KCNK12)

Potassium channel subfamily K member 12 (KCNK12) is a membrane protein encoded by the KCNK12 gene, classified as a two-pore-domain potassium (K2P) channel and part of the ion channel molecular family[1][2][3][6]. It is characterized by four transmembrane segments and forms a pseudo-tetrameric architecture. KCNK12 is primarily expressed in the kidney, notably in the proximal tubule, thick ascending limb, and cortical collecting duct, but has also been detected in dorsal root ganglia. Although the wild-type human KCNK12 protein is largely 'silent' when heterologously expressed due to retention in the endoplasmic reticulum and low channel activity, functional expression and potassium-selective currents can be induced by specific mutations. KCNK12 functions in potassium ion transmembrane transport and plays a role in stabilizing membrane potential; it is regulated by various physical, pharmacological, and endogenous factors including osmotic stress, pH, temperature, mechanical stimulation, polyunsaturated fatty acids, volatile anesthetics, and major neurotransmitters. Disease associations include roles as a DNA methylation marker in pancreatic cancer, involvement in some inflammatory processes and neurogenic pain, and reported links to skin angiosarcoma and Birk-Barel syndrome[1][2]. Drugs including fluoxetine and volatile anesthetics have modulatory effects, mainly through their influence on potassium leak current. The available literature suggests KCNK12 is a valid therapeutic target within the potassium channel family, particularly in pharmacological and biomarker research, although direct clinical targeting and safety implications remain largely unexplored in current datasets[1][2][6].

Other names

THIK-2K2p12.1Tandem pore domain halothane-inhibited potassium channel 2potassium two pore domain channel subfamily K member 12potassium channel, subfamily K, member 12tandem pore domain potassium channel THIK-2KCNKC

Modulation of potassium channel activity by physical factors (osmotic stress, pH, temperature, mechanical stimulation), neurotransmitters (nitric oxide, serotonin, norepinephrine, substance P), and pharmacological agents (volatile anesthetics, antidepressants, neuroprotective drugs); Regulation by phosphorylation or other post-translational modifications, influencing channel trafficking